FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 16:20:52 28/06/2024 BST | ||
| 62.1 EUR | -6.41% |
|
| Current month | -10.30% | ||
| 1 month | -3.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 62.1 | -6.41% |
| 27/06/24 | 66.35 | +10.69% |
| 26/06/24 | 59.94 | -2.25% |
| 25/06/24 | 61.32 | -0.33% |
| 24/06/24 | 61.52 | -5.88% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 04:20 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PN5SMY |
| ISIN | DE000PN5SMY1 |
| Date issued | 28/10/2022 |
| Strike | 41.51 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 83.42 € |
|---|---|
| Lowest since issue | 5.88 € |
| Spread | 0.13 € |
| Spread % | 0.21% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51
USD
Average target price
53.19
USD
Spread / Average Target
+28.15%
- Stock Market
- Certificates
- Certificat
